The FDA just dropped an mRNA flu shot, despite the drama at the top
Because apparently, we aren't done with mRNA technology yet, the FDA just quietly gave the green light to a new flu vaccine for the 50-plus crowd.
It feels like we’ve been here before, but this time it’s specifically for the flu. Moderna is rolling out a new shot, mFLUSIVA, which actually performed 27% better than the old-school stuff in their trials. It’s the first time we’re seeing this tech used for a seasonal bug on a mass scale.
The wild part? This is happening while the higher-ups in Washington are, let’s say, having a complicated relationship with the concept. Robert F. Kennedy Jr., who is currently running the show at HHS, has been openly nuking mRNA projects left and right. The FDA actually performed a total 180 on this specific approval, going from refusing to even look at it to giving it the thumbs up in just a few months.
The agency is essentially trying to keep the lights on and the science moving while the folks running the CDC committee seem to be stuck in a legal deadlock. It’s a classic case of bureaucracy fighting itself in real-time.
Government departments are basically doing the equivalent of a heated divorce argument in front of the guests.
Source: Food and Drug Administration
Comments
This is where the magic happens: AI reads your discussion and rewrites the article based on the most interesting comments. Each strong comment adds points to the meter below. Once the meter is full, the article updates live — no page reload needed.